Free Trial

Centiva Capital LP Cuts Stock Position in H&R Block, Inc. (NYSE:HRB)

H&R Block logo with Consumer Discretionary background

Centiva Capital LP decreased its holdings in shares of H&R Block, Inc. (NYSE:HRB - Free Report) by 53.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 15,581 shares of the company's stock after selling 17,718 shares during the quarter. Centiva Capital LP's holdings in H&R Block were worth $823,000 at the end of the most recent quarter.

Several other institutional investors also recently modified their holdings of HRB. Endeavor Private Wealth Inc. bought a new stake in shares of H&R Block during the fourth quarter worth $27,000. Spire Wealth Management bought a new stake in shares of H&R Block during the fourth quarter worth $28,000. Newbridge Financial Services Group Inc. bought a new stake in shares of H&R Block during the fourth quarter worth $29,000. GAMMA Investing LLC increased its position in shares of H&R Block by 64.5% during the fourth quarter. GAMMA Investing LLC now owns 658 shares of the company's stock worth $35,000 after acquiring an additional 258 shares in the last quarter. Finally, Thurston Springer Miller Herd & Titak Inc. increased its position in shares of H&R Block by 52.6% during the fourth quarter. Thurston Springer Miller Herd & Titak Inc. now owns 838 shares of the company's stock worth $44,000 after acquiring an additional 289 shares in the last quarter. Institutional investors and hedge funds own 90.14% of the company's stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on HRB shares. Northcoast Research lowered shares of H&R Block from a "buy" rating to a "neutral" rating in a research report on Friday, May 2nd. Barrington Research restated an "outperform" rating and issued a $70.00 price target on shares of H&R Block in a research note on Friday, April 25th. StockNews.com upgraded shares of H&R Block from a "hold" rating to a "buy" rating in a research report on Friday, May 9th. Finally, The Goldman Sachs Group lifted their price objective on shares of H&R Block from $49.00 to $54.00 and gave the company a "sell" rating in a research note on Thursday, May 8th.

View Our Latest Stock Report on H&R Block

H&R Block Stock Performance

NYSE HRB traded down $0.67 during trading on Wednesday, hitting $56.28. 500,151 shares of the company's stock traded hands, compared to its average volume of 1,379,623. H&R Block, Inc. has a 12-month low of $48.23 and a 12-month high of $68.45. The stock has a market capitalization of $7.53 billion, a price-to-earnings ratio of 15.50, a PEG ratio of 0.80 and a beta of 0.28. The company has a debt-to-equity ratio of 16.46, a quick ratio of 0.73 and a current ratio of 0.73. The business has a 50 day moving average of $56.99 and a 200-day moving average of $56.11.

H&R Block (NYSE:HRB - Get Free Report) last posted its quarterly earnings data on Wednesday, May 7th. The company reported $5.38 earnings per share for the quarter, topping the consensus estimate of $5.12 by $0.26. H&R Block had a net margin of 14.71% and a negative return on equity of 179.15%. The company had revenue of $2.28 billion for the quarter, compared to analysts' expectations of $2.25 billion. During the same period in the prior year, the business earned $4.94 earnings per share. H&R Block's revenue for the quarter was up 4.2% compared to the same quarter last year. As a group, equities research analysts anticipate that H&R Block, Inc. will post 5.25 earnings per share for the current fiscal year.

H&R Block Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 3rd. Shareholders of record on Wednesday, June 4th will be given a dividend of $0.375 per share. This represents a $1.50 annualized dividend and a yield of 2.67%. The ex-dividend date of this dividend is Wednesday, June 4th. H&R Block's dividend payout ratio is currently 36.76%.

Insider Activity

In related news, CEO Jeffrey J. Jones II sold 53,810 shares of the business's stock in a transaction that occurred on Wednesday, April 16th. The stock was sold at an average price of $63.28, for a total value of $3,405,096.80. Following the transaction, the chief executive officer now directly owns 844,790 shares of the company's stock, valued at approximately $53,458,311.20. The trade was a 5.99% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.30% of the company's stock.

H&R Block Profile

(Free Report)

H&R Block, Inc engages in the provision of tax return preparation solutions, financial products and small business solutions. The company was founded by Henry W. Bloch and Richard A. Bloch on January 25, 1955, and is headquartered in Kansas City, MO.

Featured Articles

Institutional Ownership by Quarter for H&R Block (NYSE:HRB)

Should You Invest $1,000 in H&R Block Right Now?

Before you consider H&R Block, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and H&R Block wasn't on the list.

While H&R Block currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines